Dataset: Differentially expressed transcripts in SLE blood monocytes
To better characterize the molecules that could potentially confer antigen presenting capacity to SLE monocytes, we assessed their gene...
To better characterize the molecules that could potentially confer antigen presenting capacity to SLE monocytes, we assessed their gene expression profile. Blood monocytes from five healthy controls and five pediatric SLE patients were isolated using CD14+ selection. Because drugs used to treat SLE could induce considerable transcriptional changes, we selected active, newly diagnosed patients who had never received oral or intravenous (IV) medications.
- Species:
- human
- Samples:
- 10
- Source:
- E-GEOD-46907
- PubMed:
- 24829414
- Updated:
- Jan.17, 2015
- Registered:
- Jan.17, 2015
Factors:
(via ArrayExpress)
Sample | DISEASE STATE | SUBJECT |
---|---|---|
GSM1140958 1 | healthy | H104 |
GSM1140959 1 | healthy | H152 |
GSM1140960 1 | healthy | H154 |
GSM1140961 1 | healthy | H58 |
GSM1140962 1 | healthy | H99 |
GSM1140963 1 | pediatric systemic lupus erythematosus | SLE 137 |
GSM1140964 1 | pediatric systemic lupus erythematosus | SLE 41 |
GSM1140965 1 | pediatric systemic lupus erythematosus | SLE143 |
GSM1140966 1 | pediatric systemic lupus erythematosus | SLE144 |
GSM1140967 1 | pediatric systemic lupus erythematosus | SLE145 |